Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CNPY2 antisense RNA 1 (CNPY2-AS1) is a human long noncoding RNA gene located on chromosome 12. It is transcribed on the opposite strand to the protein-coding CNPY2 gene and does not encode a protein[5]. As of now, there are no published functional studies specifically addressing the biological role of CNPY2-AS1, its involvement in disease, its utility as a diagnostic or therapeutic target, or its interactions with drugs. Its annotation in genomic databases is supported, but it remains uncharacterized in biomedical literature beyond basic sequence and location information. If the intent is to seek information on a druggable target or receptor, the protein CNPY2 (canopy homolog 2) should be investigated instead, as it has documented roles in cell survival, ER stress regulation, angiogenesis, and certain cancers[1][3][4][6].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CNPY2 antisense RNA 1 (CNPY2-AS1).